by Microbiologics | Apr 18, 2019 | Cannabis, Clinical, Food, Molecular, Pharmaceutical
Cannabis has become a widely accepted form of medicine for patients across the United States. These patients, many of whom are immunocompromised, rely on testing laboratories to ensure the safety of the products they use. The lack of consistent and clear regulations...
by Microbiologics | Feb 28, 2019 | Clinical, Molecular
Almost nine years ago, the Food and Drug Administration (FDA) held a public meeting to discuss the oversight of laboratory developed tests (LDTs). As LDTs became more complex and integral to clinical diagnostics, the agency considered a risk-based approach for...
by abrickmicrobiologicscom | Nov 26, 2018 | Pharmaceutical
Pharmaceutical microbiologists have the great responsibility of ensuring their products are free of harmful contaminants and safe for consumers. Earlier this month at the Pharmaceutical Microbiology Fall Forum in Philadelphia, Microbiologics Vice President of Research...
by Stanley Staphylococcus | Oct 18, 2018 | Clinical, Molecular
Dear Stanley, I’m completely confused about the terms “assayed” and “unassayed” in relation to controls for molecular diagnostic instruments. Does “unassayed” mean the manufacturer of the control hasn’t tested the products? Can you shed some light on...
by Tina Sobania | Sep 13, 2018 | Clinical, Molecular
There are many misconceptions in the clinical industry regarding laboratory quality control materials. With numerous products available and manufacturers using various labeling practices, how do you know what’s best for your laboratory? To help clear up the confusion,...
